DARZALEX VIAL

  • اسم المستحضر : DARZALEX VIAL
  • اسم المصنع : Cilag AG/Switzerland
  • التصنيف : Import Product
  • الوكيل / الموزع : Medical Supplies & Services (M.S.S)
  • الشكل الصيدلاني : Concentrate for solution for IV infusion
  • المكونات الفعالة : Each 1 ml contains: Daratumumab 20 mg
  • يستخدم لـ : Darzalex is indicated: •As monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, whose prior therapy included a proteasome inhibitor and an immunomodulatory agent and who have demonstrated disease progression on the last therapy. •In combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.
  • رقم التسجيل : 66/6691/5, 20
  • تاريخ التسجيل : 12-09-2018
  • تاريخ انتهاء التسجيل : 12-09-2023

Please Wait